Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blumeria graminis f. sp. tritici is an obligate biotrophic ascomycete fungus and the primary causal agent of wheat powdery mildew, a disease that significantly impacts wheat yield and quality worldwide [1][2]. As an obligate biotroph, the fungus depends entirely on living host tissues, utilizing specialized structures called haustoria to extract nutrients while keeping the host cells alive [3]. The pathogen propagates rapidly via wind-dispersed asexual conidia, but it can also undergo sexual reproduction through chasmothecia, which facilitates genetic recombination and overwintering [2][4]. While the organism itself is often the focus of agricultural control measures, it is a complex pathogen rather than a single molecular target like an enzyme or receptor [1]. Most commercial fungicides control the fungus by targeting specific molecular sites within its proteome, such as sterol 14α-demethylase in the ergosterol biosynthesis pathway or cytochrome b in the mitochondrial electron transport chain [5]. Due to its high evolutionary potential, this pathogen frequently develops resistance to fungicides, necessitating integrated pest management and the breeding of resistant wheat cultivars [2][5]. Sources: [1] Wicker et al. (2013). "Genome sequence of the wheat powdery mildew fungus..." [2] Dean et al. (2012). "The Top 10 fungal pathogens in molecular plant pathology." [3] Spanu et al. (2010). "Genome Expansion and Gene Loss in Powdery Mildew Fungi." [4] Troch et al. (2014). "The evolutionary genetics of the wheat powdery mildew fungus." [5] FRAC (Fungicide Resistance Action Committee) target site descriptions.
Various mechanisms targeting fungal metabolism, including inhibition of sterol 14α-demethylase (DMIs), inhibition of mitochondrial respiration (QoIs and SDHIs), and disruption of signal transduction or cell wall synthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blumeria graminis f. sp. tritici (Bgt).